Announcement: Updated Guidelines on Managing DrugInteractions in the Treatment of HIV-Related Tuberculosis
Guidelines for managing pharmacologic interactions that can result when patients receive antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection together with rifamycin antibiotics for treatment of tuberculosis (TB) have been published previously (1–4). Newly updated guidelines, developed by CDC in collaboration with experts from other key national and international institutions, are now available at http://www.cdc.
Media Type: Html
- SourceUrl: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6312a5.htm
- Syndication ID: 1011
- Language: English
- Source: Centers for Disease Control and Prevention (CDC)
- Date Syndication Captured: Thursday, March 27, 2014 at 09:21 PM
- Date Syndication Updated: Tuesday, May 24, 2016 at 01:32 AM
Tags
General:
treatment
guidelines
tuberculosis
announcement
managing
updated
druginteractions
hivrelated
Embed Code Snippet
To get the embed code snippet please Login.
